AKT1 and obesity disorder: Under the conditions of obesity, excessive FFAs will lead to glucose and lipid metabolism disorders, which eventually weaken the PI3K-AKT signaling pathway, thereby inducing insulin resistance (Bathina and Das, 2018), which will further affect the PI3K-AKT signaling pathway.